Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Stem Cells International|September 6, 2019
Human Amnion Epithelial Cell Therapy for Chronic Liver DiseaseNeil Andrewartha, George Yeoh
Cell Transplantation|August 20, 2020
Human Amnion Epithelial Cells Produce Soluble Factors that Enhance Liver Repair by Reducing Fibrosis While Maintaining Regeneration in a Model of Chronic Liver InjuryAlexander Hodge, Neil Andrewartha, Dinushka Lourensz, et al.
European Journal of Medicinal Chemistry|March 27, 2021
In pursuit of a selective hepatocellular carcinoma therapeutic agent: Novel thalidomide derivatives with antiproliferative, antimigratory and STAT3 inhibitory propertiesMichael J Nutt, Yeung Sing Yee, Amanda Buyan, et al.
Toxicology and Applied Pharmacology|September 14, 2010
Uptake and cytotoxicity of chitosan nanoparticles in human liver cellsJing Wen Loh, George Yeoh, Martin Saunders, et al.
Stem Cell Research & Therapy|July 29, 2021
Addressing the liver progenitor cell response and hepatic oxidative stress in experimental non-alcoholic fatty liver disease/non-alcoholic steatohepatitis using amniotic epithelial cellsMihiri Goonetilleke, Nathan Kuk, Jeanne Correia, et al.
Immunology and Cell Biology|July 22, 2005
Liver inflammation and cytokine production, but not acute phase protein synthesis, accompany the adult liver progenitor (oval) cell response to chronic liver injuryBelinda Knight, Vance B Matthews, Barbara Akhurst, et al.
Tissue Engineering. Part C, Methods|October 19, 2010
Expansion and hepatocytic differentiation of liver progenitor cells in vivo using a vascularized tissue engineering chamber in miceNatasha Forster, Jason A Palmer, George Yeoh, et al.
Stem Cells and Development|October 31, 2009
Human liver progenitor cell lines are readily established from non-tumorous tissue adjacent to hepatocellular carcinomaAibin Zhang, Roslyn London, Frederik Michael Schulz, et al.
The Journal of Cell Biology|July 9, 2008
TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1-TRAF2 complex to sensitize tumor cells to TNFalphaJames E Vince, Diep Chau, Bernard Callus, et al.
Cancers|October 13, 2021
Maraviroc Prevents HCC Development by Suppressing Macrophages and the Liver Progenitor Cell Response in a Murine Chronic Liver Disease ModelAdam M Passman, Robyn P Strauss, Sarah B McSpadden, et al.
Pageof 2